Skip to Main Content

Paper Details

The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Am J Hematol
42
2020
AML, BCL-2, TP53, TP53 mutations, acute myeloid leukemia, hematologic malignancy, hematopoietic cell, leukemia, myeloid disease, patients, venetoclax
Author NameAffiliation
Paul Brent FerrellVanderbilt University School of Medicine
Paul Brent FerrellVanderbilt-Ingram Cancer Center
Paul Brent FerrellVanderbilt University School of Medicine
Paul Brent FerrellVanderbilt-Ingram Cancer Center
Adetola A KassimVanderbilt University School of Medicine
Adetola A KassimVanderbilt-Ingram Cancer Center
  • 1 - 6

Datasets

Release 1.2